Pharmacokinetics and Bioavailability Comparison of 20-mg generic and branded Citalopram Tablets: an Open-label, Randomized Sequence, Two-Period Crossover Study in Healthy Chinese CYP2C19 Extensive Metabolizers

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2012
INTERVENTION: 2:citalopram 20‐mg tablets ; CONDITION: Major depression PRIMARY OUTCOME: pharmacokinetic property; INCLUSION CRITERIA: age 18 to 40 years; body mass index between 20 and 24 kg/m2; and CYP2C19 genotype of *1/*1, *1/*2, or *1/*3
Epistemonikos ID: fea1b84be6073723cef485ed5c456a23d078aa5c
First added on: Aug 22, 2024